S&P Futures
4,328.00 +3.75 (+0.09%) Dow Futures
33,663.00 +25.00 (+0.07%) Nasdaq Futures
14,989.00 +4.25 (+0.03%) Russell 2000 Futures
1,770.70 -0.70 (-0.04%) Crude Oil
88.71 -0.11 (-0.12%) Gold
1,841.80 -5.40 (-0.29%)
Sarepta Therapeutics, Inc. (SRPT)
After hours:
Chart Events
Performance Outlook
| Previous Close | 121.22 |
| Open | 120.40 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1300 |
| Day's Range | 118.09 - 121.67 |
| 52 Week Range | 100.15 - 159.89 |
| Volume | |
| Avg. Volume | 904,341 |
| Market Cap | 11.062B |
| Beta (5Y Monthly) | 0.94 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.07 |
| Earnings Date | Oct 31, 2023 - Nov 06, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 180.94 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for SRPT
Related Research
- Sarepta Therapeutics, Inc.Daily – Vickers Top Buyers & Sellers for 09/16/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moatlast yearArgus Research
Business WireSarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., September 29, 2023--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on September 29, 2023 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan, as a material inducement to employment to 24 individuals hired by Sarepta in September 2023. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(
Investor's Business DailyHave Million-Dollar Gene Therapies Finally Reached An Inflection Point?
The big names behind biotech stocks no longer want to merely treat diseases, they want to cure them. But it's going to be costly.
Motley Fool2 Top Growth Stocks to Buy With $500
Here are two companies to consider: Sarepta Therapeutics (NASDAQ: SRPT) and Shopify (NYSE: SHOP). Sarepta Therapeutics is a biotech company that focuses on developing medicines for rare diseases. Sarepta Therapeutics' portfolio of DMD therapies is generating consistently growing sales.
